For expert network information on Vir Biotechnology careers, use Ladders $100K+ Club. Visit PayScale to research research technician, biotechnology salaries by city, experience, skill, employer and more. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis. 50 Biotechnology jobs available in Virginia on A free inside look at Vir Biotechnology bonus trends based on 3 bonuses wages for 3 jobs at Vir Biotechnology. The average salary for a Research Technician, Biotechnology is $44,986. The companies plan to meet with the US Food and Drug Administration (FDA) and other regulatory authorities to discuss accelerating their filing for starting the trials of the inhaled therapy. Salaries, reviews and more - all posted by employees working at Vir Biotechnology. The Registered Agent on file for this company is Corporation Service Company Which Will Do Business In California As Csc - Lawyers Incorporating Serv and is located at 2710 Gateway Oaks Dr Ste 150n, Sacramento, CA 95833. See what employees say about what it's like to work at Vir Biotechnology. Investor Activity Vir Biotechnology has actively raised capital from investors.

Note: Vir Biotechnology's revenues are gauged from an analysis of company filings.

See the company profile for Vir Biotechnology, Inc. (VIR), including business summary, industry/sector information, number of employees, corporate governance, key executives and salary information. The company's filing status is listed as Active and its File Number is C4022288. Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. These investors may include private investors, venture capital firms, or other investment vehicles.

The San Francisco-based company sold 7.14 million shares Wednesday for $20 each, it said in a statement. Vir Biotechnology is a clinical-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases. What are the highest paying jobs at Vir Biotechnology? Apply to Research Scientist, Research Associate, Intern and more! (Bloomberg) -- Vir Biotechnology Inc., which develop treatments for infectious diseases, raised $143 million after pricing its U.S. initial public offering at the low end of a marketed range.

Only 72% pay more than $100K. Vir Biotechnology, Inc. is a California Foreign Corporation filed on May 10, 2017. Vir Biotechnology Inc and Alnylam Pharmaceuticals Inc have identified a drug candidate for treating COVID-19 and plan to begin human testing by the end of the year, the companies said on Monday.

The company brings together cutting-edge innovations with scientific expertise and management. Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions.